Location: New York, NY
CIK: 0001017645 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $2.873B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DLO | DLOCAL | 46,656,695 | $660M | 23.0% | $34.47 | -59.1% | CL A | G29018101 |
| CHYM | CHIME | 21,259,683 | $535M | 18.6% | $31.82 | -33.2% | COM SHS CL A | 16935C109 |
| XP | XP, INC | 22,699,133 | $372M | 12.9% | $31.26 | -43.7% | CL A | G98239109 |
| ALKT | ALKAMI | 11,991,480 | $277M | 9.6% | $34.49 | -36.0% | COM | 01644J108 |
| ALHC | ALIGNMENT HEALTHCARE | 13,167,733 | $260M | 9.1% | $19.55 | -8.1% | COM | 01625V104 |
| RVMD | REVOLUTION MEDICINES | 2,812,928 | $224M | 7.8% | $42.33 | +54.9% | COM | 76155X100 |
| PHVS | PHARVARIS | 8,031,252 | $223M | 7.8% | $22.20 | +8.5% | COM | N69605108 |
| CNTA | CENTESSA PHARMACEUTICALS | 6,117,715 | $153M | 5.3% | $17.55 | — | ADS | 152309100 |
| NRIX | NURIX THERAPEUTICS | 4,897,159 | $92.9M | 3.2% | $14.37 | 0.0% | COM | 67080M103 |
| EWCZ | EUROPEAN WAX CENTER | 13,110,492 | $47.2M | 1.6% | $22.36 | -83.3% | CL A | 29882P106 |
| RSKD | RISKIFIED | 5,324,998 | $26.47M | 0.9% | $28.06 | -82.8% | CL A | M8216R109 |
| GROV | GROVE COLLABORATIVE | 2,474,859 | $2.722M | 0.1% | $1.69 | -19.3% | CL A | 39957D201 |
| BULL | WEBULL | 50,816 | $395K | 0.0% | $14.98 | -32.9% | ORD SHS | G9572D103 |